Rheumation (RA) is a long -term autoimmune disorder that mainly affects the joints, causing chronic swelling, pain, hardness and inflammation. It can damage cartilage, bones and surrounding tissues, causing deformity, disability and systemic complications if not treated immediately.
This normal type refers to the rheumatoid factor and anti-CCP antibodies, causing severe inflammation and progressive joint damage.
Patients perform negative tests for rheumatoid factor, but still experience frequent swelling, swelling, hardness and joint pain.
There is in children under the age of 16, which presents joint swelling, hardness, persistent pain and disturbances of growth.
The firm appears with the firm nodule near the joints, usually associated with severe, chronic and progressive disease.
Constant pain, tenderness and swelling occur in many joints, especially small joints of hands and feet.
Patients often experience stiffness lasting for more than 30 minutes in the morning, which gradually improves with movement.
Both sides of the body are equally affected, which usually include wrist, knee and finger joints.
Patients often experience tired, weak and energy loss that is caused by ongoing inflammation.
Chronic disease can be the cause of joint deformity and firm nodules under the skin near the joints.
Anti-CCP antibodies are highly specific for rheumatism. Their presence indicates an aggressive disease course. This test is useful for initial diagnosis and effectively predicts the severity and progress of rheumatism.
ESR measures the rate on which red blood cells live in a test tube. A high value indicates systemic inflammation. This disease helps in assessing activity and monitoring the treatment reaction in rheumatic patients.
CRP is a protein that increases with inflammation. High levels suggest active disease. It is commonly used to monitor the effectiveness of treatment and identify the inflammation in rheumatoid patients.
CBC helps identify the anemia of chronic disease, which is common in rheumatism. It also detects infections, leukocytosis and platelet abnormalities, assisting in the overall evaluation of the patient’s health status.
X-rays manifest the deformity caused by joint space narrowness, bone erosion, and rheumatoid arthritis. Although changes appear later, they help affected joints to assess severity, progress and long -term damage.
The musculoskeletal ultrasound detects joint inflammation, synovitis, and effigies that do not appear on the X-ray. It is sensitive, non-invasive, and is helpful to monitor the reaction of treatment and detect subtle structural changes in the joints.
MRI provides detailed imaging of bones, cartilage and soft tissues. It detects early erosion, synovitis and inflammation with high accuracy. MRI is useful for evaluation of initial diagnosis and disease progression.
This test involves withdrawing the mucus fluid from inflammatory joints. Analysis helps to remove infection, crystal-induced arthritis or gout. Conclusion often shows inflammatory fluid in patients with rheumatism.
These tests do not directly diagnose rheumatism, but are necessary before starting drugs. Medications such as methotrexate affect liver and kidney functions, so monitoring ensures the safety and effective treatment management of the patient.
Copyright © 2025 – Designed by Camsol Advertising